当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2024-07-30 , DOI: 10.1002/ejhf.3397
Jasper Tromp 1, 2, 3 , Carolyn S P Lam 2 , Wendimagegn Alemayehu 4 , Christopher R de Filippi 5 , Vojtěch Melenovský 6 , Karen Sliwa 7 , Yuri Lopatin 8 , Juan Luis Arango 9 , M Cecilia Bahit 10 , Lothar Roessig 11 , Christopher M O'Connor 5 , Palak Shah 5 , Cynthia M Westerhout 4 , Adriaan A Voors 3, 12 , Burkert Pieske 13 , Paul W Armstrong 4 ,
Affiliation  

Reverse ventricular remodelling, defined as a decrease in left ventricular end-systolic volume indexed to body surface area (LVESVI) or an increase in left ventricular ejection fraction (LVEF), is associated with improved clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). However, the underlying pathophysiological mechanisms remain unclear.

中文翻译:


射血分数降低的心力衰竭患者与反向心室重塑相关的生物标志物谱:来自 VICTORIA 试验超声心动图子研究的见解



反向心室重塑,定义为与体表面积 (LVESVI) 相关的左心室收缩末期容积减少或左心室射血分数 (LVEF) 增加,与射血分数降低 (HFrEF) 心力衰竭患者的临床结局改善有关。然而,潜在的病理生理机制仍不清楚。
更新日期:2024-07-30
down
wechat
bug